Quick Facts
Generic NameCariprazine
Brand NameVraylar
Drug ClassSGA
FDA Approved2015
Starting Dose1.5mg/day
Typical Range1.5–6mg/day
Max Dose6mg/day
Half-Life2–4 days (active metabolite: 1–3 weeks)
MetabolismCYP3A4 (major)
Generic AvailableNot yet generic
What Is Vraylar?
Cariprazine (brand name Vraylar) is a second-generation (atypical) antipsychotic (SGA) prescribed for schizophrenia, bipolar disorder, bipolar depression, and other psychiatric conditions. Only D3-preferring antipsychotic. FDA-approved for bipolar depression (rare among SGAs). Extremely long effective half-life (active metabolites persist 1–3 weeks). May improve negative symptoms and anhedonia better than other SGAs.
At Psychiatry Telemed, cariprazine is prescribed and monitored by board-certified psychiatrists who understand the nuances of SGA pharmacology — selecting the right dose, managing side effects, monitoring drug interactions, and optimizing your treatment through consistent monthly medication management appointments.
Cariprazine (Vraylar) — SGA medication for psychiatric care
ManufacturerAbbVie (originally Actavis)
How Vraylar Affects Neurotransmitters
How Vraylar Works
Cariprazine is unique among antipsychotics as a D3-preferring partial agonist (10x higher affinity for D3 than D2). D3 receptors are concentrated in limbic regions involved in motivation, reward, and cognition — which may explain its effectiveness for negative symptoms and bipolar depression.
Efficacy: Vraylar vs. Comparators
Efficacy Comparison
Response & remission rates vs. comparators (Cipriani et al. meta-analysis)
Data from published meta-analyses. Individual response may vary.
Conditions Treated with Vraylar
Bipolar Disorder
FDA-approved for bipolar mania, mixed episodes, and bipolar depression.
Learn About Bipolar DisorderConsidering Vraylar?
Board-certified psychiatrists can determine if cariprazine is right for you.
Dosage Information
| Indication | Starting Dose | Typical Range | Maximum |
|---|---|---|---|
| Schizophrenia | 1.5mg/day | 1.5–6mg/day | 6mg/day |
| Bipolar Disorder | 1.5mg/day | 1.5–6mg/day | 6mg/day |
| Bipolar Depression | 1.5mg/day | 1.5–6mg/day | 6mg/day |
Brain Regions Targeted by Vraylar
Side Effects
Like all medications, cariprazine has potential side effects. Most are mild, occur early in treatment, and resolve within 1–2 weeks. Your psychiatrist monitors at every appointment.
Common Side Effects
Weight GainDrowsiness/SedationDizzinessMetabolic EffectsAkathisiaDry Mouth
Less Common
Orthostatic HypotensionConstipationEPS/TremorProlactin ElevationQTc Changes
Serious (Seek Immediate Help)
Metabolic SyndromeNeuroleptic Malignant SyndromeTardive DyskinesiaDiabetic Ketoacidosis
Side Effect Profile: Vraylar vs. Class Average
Side Effect Profile
Incidence rates from FDA prescribing information vs. class average
Percentages from clinical trial data. Actual experience may differ.
⚠️ FDA Black Box Warning
Elderly patients with dementia-related psychosis treated with antipsychotics are at increased risk of death. Antipsychotics are not approved for dementia-related psychosis.
Drug Interactions
Major Interactions
CNS depressants (additive sedation), CYP inhibitors/inducers (varies by drug), QTc-prolonging agents
CYP Metabolism
Substrate of CYP3A4 (major). Consult drug interaction database for specific combinations.
Alcohol
Avoid alcohol during cariprazine treatment. Both affect the CNS, increasing sedation and impairing judgment.
Generic Versions & Cost
Generic cariprazine available since Not yet generic. Approximate cost: $300+/month (brand only). FDA-certified bioequivalent to brand-name Vraylar.
Starting Vraylar: What to Expect
First Weeks
Cariprazine is typically started at 1.5mg/day and increased gradually. Common initial side effects usually improve within 1–2 weeks. Full therapeutic benefit develops over 4–8 weeks.
When to Contact Your Psychiatrist
Contact your psychiatrist for: worsening depression/anxiety, thoughts of self-harm, unusual agitation, severe side effects, or any concerning changes.
Stopping Vraylar Safely
Never stop cariprazine abruptly. Your psychiatrist will develop a gradual tapering schedule to minimize discontinuation effects.
Timeline: When Vraylar Starts Working
Timeline to Effectiveness
Expected improvement trajectory over the first 8 weeks
Based on clinical trial data. Full therapeutic effects may take 6–8 weeks.
Get Vraylar from a Board-Certified Psychiatrist
At Psychiatry Telemed, cariprazine is prescribed following comprehensive evaluation. All Florida via HIPAA-compliant telepsychiatry. 1–3 days. $299 eval, $149 follow-up.
Frequently Asked Questions
Prescribed for schizophrenia, bipolar disorder, bipolar depression.
Typically 2–4 weeks for initial improvement, 4–8 weeks for full benefit.
Common: weight gain, drowsiness/sedation, dizziness, metabolic effects, akathisia. Most resolve within 1–2 weeks.
No. Not habit-forming but should not be stopped abruptly — gradual tapering recommended.
Only D3-preferring antipsychotic. FDA-approved for bipolar depression (rare among SGAs). Extremely long effective half-life (active metabolites persist 1–3 weeks). May improve negative symptoms and an
Alcohol should be avoided — increases sedation, impairs judgment, and may worsen symptoms.
Resources
Medical Disclaimer: Educational only. Consult a psychiatrist before starting/stopping medication. Crisis: call 988 or 911.
Last reviewed: